COVID-19 and therapeutic drugs repurposing in hand: The need for collaborative efforts
- 1 March 2021
- journal article
- review article
- Published by Elsevier BV in Le Pharmacien Hospitalier et Clinicien
- Vol. 56 (1), 3-11
- https://doi.org/10.1016/j.phclin.2020.06.003
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell CultureAntimicrobial Agents and Chemotherapy, 2014
- Anticoagulants: A Review of the Pharmacology, Dosing, and ComplicationsCurrent Emergency and Hospital Medicine Reports, 2013
- Novel antiviral activity of baicalein against dengue virusBMC Complementary and Alternative Medicine, 2012
- The Application and Mechanism of Action of Ribavirin in Therapy of Hepatitis CAntiviral Chemistry and Chemotherapy, 2012
- EPs® 7630 (Umckaloabo®), an extract from Pelargonium sidoides roots, exerts anti-influenza virus activity in vitro and in vivoAntiviral Research, 2012
- Anti-influenza virus effect of aqueous extracts from dandelionVirology Journal, 2011
- Interferon-inducible antiviral effectorsNature Reviews Immunology, 2008
- The Pharmacokinetics and Interactions of Ivermectin in Humans—A Mini-reviewThe AAPS Journal, 2008
- Interferons at age 50: past, current and future impact on biomedicineNature Reviews Drug Discovery, 2007
- Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findingsThorax, 2004